Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in Norway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in Norway

Published:2021-08-02 Issue:9 Volume:60 Page:1146-1153
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Støer Nathalie C.¹,Bouche Gauthier²,Pantziarka Pan²,Sloan Erica K.³⁴,Andreassen Bettina K.¹,Botteri Edoardo¹⁵

Affiliation:

1. Department of Research, Cancer Registry of Norway, Oslo, Norway

2. Anticancer Fund, Brussels, Belgium

3. Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia

4. Division of Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

5. Section for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo, Norway

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2021.1953136

Reference57 articles.

1. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

2. Global Burden of 5 Major Types of Gastrointestinal Cancer

3. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018

4. Therapeutic developments in pancreatic cancer: current and future perspectives

5. Drug repurposing in oncology—patient and health systems opportunities

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association between Use of Renin-Angiotensin-Aldosterone System Inhibitors and the Risk and Mortality of Pancreatic Cancer: A Systematic Review and Meta-Analysis;Current Reviews in Clinical and Experimental Pharmacology;2024-04-16

2. Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands;JAMA Surgery;2024-04-01

3. Beta‐blocker use and survival after pancreatic cancer surgery: A nationwide population‐based cohort study;Pharmacoepidemiology and Drug Safety;2023-11-09

4. A Systematic Review and Meta-analysis on the Role of Statins in the Prevention of Mortality Following Pancreatic Cancer;Anti-Cancer Agents in Medicinal Chemistry;2023-11

5. Impact of preoperative statin medication on long-term outcomes after pancreatoduodenectomy for ductal adenocarcinoma: an international multicentric cross-sectional study;Journal of Cancer Research and Clinical Oncology;2023-09-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3